COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 1984: Articles 19831-19840  | Next

The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses.
Castanon, A., Rebolj, M., Pesola, F., Sasieni, P.
10.1101/2020.11.30.20240754 — Posted: 2020-11-30
A psychrometric model to predict the biological decay of the SARS-CoV-2 virus in aerosols
Beggs, C. B., Avital, E. J.
10.1101/2020.11.29.20240408 — Posted: 2020-11-30
Change of dominant strain during dual SARS-CoV-2 infection
Samoilov, A. E., Kaptelova, V. V., Bukharina, A. Y., Shipulina, O. Y., Korneenko, E. V., Lukyanov, A. V., Grishaeva, A. A., Ploskireva, A. A., Speranskaya, A. S., Akimkin, V. G.
10.1101/2020.11.29.20238402 — Posted: 2020-11-30
How effective are the COVID-19 vaccines? A Bayesian analysis
Wibbens, P. D.
10.1101/2020.11.30.20240671 — Posted: 2020-11-30
Impact of comorbidities on COVID-19 outcome
khedr, E. M., Daef, E., Mohamed-Hussein, A., Mostafa, E. F., Zein, M., Hassany, S. M., Galal, H., Hassan, S. A., sayed, i. g., Zarzour, A. A., Hetta, H. F., Hassan, H. M., Amin, M. T., Hashem, M. K.
10.1101/2020.11.28.20240267 — Posted: 2020-11-30
'When will this end? Will it end?' The impact of the March-June 2020 UK Covid-19 lockdown response on mental health: a longitudinal survey of mothers in the Born in Bradford study.
Dickerson, J., Kelly, B., Lockyer, B., Bridges, S., Cartwright, C., Willan, K., Shire, K., Crossley, K., Bryant, M., Siddiqi, N., Sheldon, T. A., Lawlor, D. A., Wright, J., McEachan, R. R., Pickett, K. E.
10.1101/2020.11.30.20239954 — Posted: 2020-11-30
Comparative analysis of variation in the quality and completeness of local outbreak control plans for SARS-CoV-2 in English local authorities
Yu, X., Li, M., Lawson-Portuphy, L., Chowdhury, A., Badrinath, P.
10.1101/2020.11.30.20240739 — Posted: 2020-11-30
Nationwide SARS-CoV-2 Surveillance Study for Sewage and Sludges of Wastewater Treatment Plants in Turkey
Alpaslan Kocamemi, B., Kurt, H., Sait, A., Kadi, H., Sarac, F., Aydin, I., Saatci, A. M., Pakdemirli, B.
10.1101/2020.11.29.20240549 — Posted: 2020-11-30
CLINICAL TRIALS IN COVID-19 MANAGEMENT & PREVENTION: A META-EPIDEMIOLOGICAL STUDY EXAMINING METHODOLOGICAL QUALITY
Honarmand, K., Penn, J., Agarwal, A., Siemieniuk, R., Brignardello-Petersen, R., Bartoszko, J., Zeraatkar, D., Agoritsas, T., Burns, K., Fernando, S., Foroutan, F., Ge, L., Lamontagne, F., Jiminez-Mora, M. A., Murthy, S., Yepes-Nunez, J. J., Vandvik, P. O., Ye, Z., Rochwerg, B.
10.1101/2020.11.29.20237875 — Posted: 2020-11-30
Predicting Trends of Coronavirus Disease (COVID19) Using SIRD and Gaussian-SIRD Models
Sedaghat, A., MOSAVI, A.
10.1101/2020.11.29.20240499 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).